CHU Dupuytren

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Metastatic breast cancer2 trials
• Ovarian cancer1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Recruiting1 trial

Lead sponsor

• UNICANCER2 trials
• Institut Gustave Roussy1 trial

Running trials

• Active, not recruiting

  Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy

  NCT01805271· Phase 3· UNICANCER· Source

• Active, not recruiting

  Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment

  NCT01376752· Phase 3· UNICANCER· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Ovarian cancer1 recruiting

Closed trials

• Completed

  Impact of neoadjuvant immunotherapy in early stage breast cancer before standard therapy (BIS-Program)

  2024-512826-26-00· Phase 2· Institut Gustave Roussy· Source